Form Type: 4

SEC EDGAR Link
Accession Number:0001628908-21-000137
Date:2021-10-18
Issuer: EVOLENT HEALTH, INC. (EVH)
Original Submission Date:

Reporting Person:

WILLIAMS FRANK J
C/O EVOLENT HEALTH, INC.
800 NORTH GLEBE ROAD, SUITE 500 ARLINGTON, VA 22203

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
CLASS A COMMON STOCK 2021-10-18 M 10,000 a $3.84 617,809 direct
CLASS A COMMON STOCK 2021-10-18 S 10,000 d $30.35 607,809 direct
CLASS A COMMON STOCK 2021-10-18 S 10,000 d $30.35 597,809 direct
CLASS A COMMON STOCK 2021-10-18 0 $0.00 66,064 indirect f4
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
CLASS A COMMON STOCK OPTION (RIGHT TO BUY) 3.84 2021-10-18 deemed execution date M 10,000 (d) 2024-04-01 class a common stock 10,000 $3.84 639,060 direct
Footnotes
IDfootnote
f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on march 11, 2021.
f2 includes restricted stock units granted under awards reported on table 1 of form 4s previously filed with the securities and exchange commission.
f3 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $29.71 to $30.55, inclusive. the reporting person undertakes to provide to evolent health, inc., any security holder of evolent health, inc., or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
f4 shares held of record by the frank williams irrevocable trust. mr. williams serves as the trustee of the frank williams irrevocable trust.
f5 the class a common stock options exercised vested on december 1, 2014.

Elevate your investments